TABLE 3.
β (95% CI) p value | |||
|
|||
Non-adjusted | Adjust I | Adjust II | |
Total | |||
0.03 ± 0.01 | Ref. | Ref. | Ref. |
0.10 ± 0.05 | −3.49 (−5.25, −1.72) 0.0001 | −1.89 (−3.45, −0.32) 0.0190 | −1.70 (−3.27, −0.14) 0.0344 |
Male | |||
0.03 ± 0.01 | Ref. | Ref. | Ref. |
0.10 ± 0.05 | −2.72 (−4.92, −0.52) 0.0168 | −0.92 (−2.75, 0.90) 0.3218 | −1.01 (−2.84, 0.82) 0.2808 |
Female | |||
0.03 ± 0.01 | Ref. | Ref. | Ref. |
0.10 ± 0.04 | −5.43 (−8.13, −2.72) 0.0003 | −5.80 (−8.72, −2.88) 0.0003 | −5.54 (−8.78, −2.30) 0.0020 |
P for interaction | 0.1713 | 0.0114 | 0.0129 |
Adjusted model 1 was adjusted for risk factors of CSVD (Fazekas; age; hypertension; diabetes; coronary heart disease; and stroke). Adjusted model 2 was adjusted for all covariables. SFR denotes Sylvian fissure ratio.